ZA968847B - Use of hyaluronan in gene therapy - Google Patents

Use of hyaluronan in gene therapy

Info

Publication number
ZA968847B
ZA968847B ZA968847A ZA968847A ZA968847B ZA 968847 B ZA968847 B ZA 968847B ZA 968847 A ZA968847 A ZA 968847A ZA 968847 A ZA968847 A ZA 968847A ZA 968847 B ZA968847 B ZA 968847B
Authority
ZA
South Africa
Prior art keywords
hyaluronan
gene therapy
therapy
gene
Prior art date
Application number
ZA968847A
Inventor
Eva Anne Turley
Samuel Simon Asculai
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Priority to ZA968847A priority Critical patent/ZA968847B/en
Publication of ZA968847B publication Critical patent/ZA968847B/en

Links

ZA968847A 1996-10-22 1996-10-22 Use of hyaluronan in gene therapy ZA968847B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA968847A ZA968847B (en) 1996-10-22 1996-10-22 Use of hyaluronan in gene therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA968847A ZA968847B (en) 1996-10-22 1996-10-22 Use of hyaluronan in gene therapy

Publications (1)

Publication Number Publication Date
ZA968847B true ZA968847B (en) 1997-07-30

Family

ID=25585966

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968847A ZA968847B (en) 1996-10-22 1996-10-22 Use of hyaluronan in gene therapy

Country Status (1)

Country Link
ZA (1) ZA968847B (en)

Similar Documents

Publication Publication Date Title
ZA9710339B (en) Xanthines and their therapeutic use
GB9622500D0 (en) Therapeutic gene
HRP970063A2 (en) Triazole derivatives useful in therapy
AU7623096A (en) Use of epinastine in the treatment of pain
GB9609641D0 (en) Compounds useful in therapy
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
AU7272196A (en) Use of hyaluronan in gene therapy
HK1063004A1 (en) Oxalatoplatin and 5-fluorouracil for combination therapy of cancer
GB9620777D0 (en) Therapeutic use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
ZA968847B (en) Use of hyaluronan in gene therapy
ZA95508B (en) Use of flavolignans as adjuvants in tumour therapy
GB9421223D0 (en) Tissue imaging in gene therapy
GB9613629D0 (en) Reg gene expression in cancer tissue
GB9604400D0 (en) Compounds useful in therapy
AU2713797A (en) Depigmentating agent in the treatment of melasma
GB9616504D0 (en) Therapeutic product and its use
AU4938397A (en) Methods of elevating amounts of hyaluronan in the human body
GB2333527B (en) Therapeutic gene
GB9621314D0 (en) Substances and their therapeutic use
GB9609521D0 (en) Substances and their therapeutic use
GB9418696D0 (en) Gene therapy
GB9616508D0 (en) Therapeutic product and its use
GB9616823D0 (en) Therapeutic product and its use
GB9616507D0 (en) Therapeutic product and its use